Divalproex sodium and Biktarvy drug interactions - a phase IV clinical study of FDA data

Summary:

Drug interactions are reported among people who take Divalproex sodium (divalproex sodium) and Biktarvy (bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate). Common drug interactions include pain among females and anhedonia among males.

The phase IV clinical study analyzes what interactions people have when they take Divalproex sodium and Biktarvy. It is created by eHealthMe based on reports of 21 people who take the same drugs from the FDA, and is updated regularly.

What is Divalproex sodium?

Divalproex sodium has active ingredients of divalproex sodium. It is often used in epilepsy. eHealthMe is studying from 9,483 Divalproex sodium users. Check the latest studies of Divalproex sodium.

What is Biktarvy?

Biktarvy has active ingredients of bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate. It is often used in hiv infection. eHealthMe is studying from 19,543 Biktarvy users. Check the latest studies of Biktarvy.



On Jul, 28, 2026

21 people who take Divalproex sodium and Biktarvy together, and have interactions are studied.

Divalproex sodium and Biktarvy drug interactions.

What are the common drug interactions of Divalproex Sodium and Biktarvy, by gender? *:

female:

  1. Pain
  2. Anxiety
  3. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  4. Blood creatinine increased
  5. Emotional distress
  6. Osteoporosis (bones weak and more likely to break)
  7. Chronic kidney disease
  8. Back pain
  9. Depression
  10. Liver disorder (liver diseases)

male:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  4. Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
  5. Lower limb fracture
  6. Osteonecrosis (death of bone)
  7. Tooth loss
  8. Decreased activity
  9. Depression
  10. Fatigue (feeling of tiredness)

What are the common drug interactions of Divalproex Sodium and Biktarvy, by age (0-1 to 60+)? *:

0-1:

n/a

2-9:

n/a

10-19:

n/a

20-29:

n/a

30-39:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Bone density decreased
  4. Emotional distress
  5. Hand fracture
  6. Musculoskeletal disorder (disease of the body's muscles, joints, tendons, ligaments and nerves)
  7. Osteopenia (a condition where bone mineral density is lower than normal)
  8. Osteoporosis (bones weak and more likely to break)
  9. Pain
  10. Rib fracture

40-49:

  1. Pain
  2. Anxiety
  3. Blood creatinine increased
  4. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  5. Chronic kidney disease
  6. Emotional distress
  7. Osteoporosis (bones weak and more likely to break)
  8. Bone density decreased
  9. Depression
  10. Liver disorder (liver diseases)

50-59:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Emotional distress
  4. Pain
  5. Chronic kidney disease
  6. Renal failure (kidney dysfunction)
  7. Fanconi syndrome acquired (self developed genetic disease of kidney damage due to defective transport system)
  8. Glomerulonephritis membranous (nephritis with inflammation of the capillary loops in the renal glomeruli)
  9. Lower limb fracture
  10. Osteonecrosis (death of bone)

60+:

  1. Anhedonia (inability to experience pleasure from activities usually found enjoyable)
  2. Anxiety
  3. Pain
  4. Pain in extremity
  5. Pain in jaw
  6. Quality of life decreased
  7. Rib fracture
  8. Spinal fracture (fracture in one of vertebrae)
  9. Arthralgia (joint pain)
  10. Back pain

What are the existing conditions these people have? *

  1. Nausea (feeling of having an urge to vomit): 5 people, 23.81%
  2. Stress And Anxiety: 3 people, 14.29%
  3. Pain: 3 people, 14.29%
  4. Gastroesophageal Reflux Disease (a condition in which stomach contents leak backward from the stomach into the oesophagus): 3 people, 14.29%
  5. Depression: 3 people, 14.29%
  6. Seizures (abnormal excessive or synchronous neuronal activity in the brain): 2 people, 9.52%
  7. Muscle Spasms (muscle contraction): 2 people, 9.52%
  8. Insomnia (sleeplessness): 2 people, 9.52%
  9. High Blood Pressure: 2 people, 9.52%
  10. Bipolar Disorder (mood disorder): 2 people, 9.52%

* Approximation only. Some reports may have incomplete information.

Do you take Divalproex sodium and Biktarvy?

- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously



Related studies:

Effectiveness of, side effects of, and alternative drugs to the 2 drugs:

Browse all drug interactions of Divalproex sodium and Biktarvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Sub-studies by gender and age:

Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+

Browse all side effects of Divalproex sodium:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all side effects of Biktarvy:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Divalproex sodium and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Browse all interactions between Biktarvy and drugs from A to Z:

a b c d e f g h i j k l m n o p q r s t u v w x y z

How the study uses the data?

The study uses data from the FDA. It is based on divalproex sodium and bictegravir sodium; emtricitabine; tenofovir alafenamide fumarate (the active ingredients of Divalproex sodium and Biktarvy, respectively), and Divalproex sodium and Biktarvy (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

How to use the study?

DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.

Who is eHealthMe?

With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.



Recent studies on eHealthMe: